MONKEYPOX (MPOX)
Clinical trials for MONKEYPOX (MPOX) explained in plain language.
Never miss a new study
Get alerted when new MONKEYPOX (MPOX) trials appear
Sign up with your email to follow new studies for MONKEYPOX (MPOX), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mpox vaccine upgrade: new manufacturing method tested in 970 adults
⭐️ VACCINE ⭐️ OngoingThis study tests whether the MVA-BN mpox vaccine works just as well when made in a different type of cell. About 970 healthy adults aged 18 to 49 will receive two doses. Researchers will compare immune responses and side effects between the standard and new production methods.
Matched conditions: MONKEYPOX (MPOX)
Phase: PHASE2 • Sponsor: Bavarian Nordic • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 18:12 UTC
-
Child-Safe mpox vaccine trial shows promise for younger ages
⭐️ VACCINE ⭐️ OngoingThis study tests whether the MVA-BN vaccine, already used in adults, works safely in children aged 2 to 12 to prevent mpox, smallpox, and similar viruses. About 460 participants, including children and adults, will receive two doses four weeks apart. Researchers will measure immu…
Matched conditions: MONKEYPOX (MPOX)
Phase: PHASE2 • Sponsor: Bavarian Nordic • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:57 UTC